GNRH1 and neoplasm: In previous studies, a wide range of modifications on the primary GnRH-III sequence have been performed in order to increase the anti-tumor activity of the conjugates by eliciting a favorable influence on the GnRH-R binding affinity, stability, cellular uptake rates and drug releasing properties [24,25,26].